Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage

The present disclosure relates to glycan-based biomarkers for the diagnosis or prognosis of brain damage, such as traumatic brain injury (TBI).

Saved in:
Bibliographic Details
Main Author Harel, Adrian
Format Patent
LanguageEnglish
Published 26.11.2020
Subjects
Online AccessGet full text

Cover

Loading…